A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)
SPI-62-CL-1002
Phase 1 other active
Quick answer
A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR) for polymyalgia rheumatica is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- polymyalgia rheumatica
- Phase
- Phase 1
- Modality
- other
- Status
- active